A digital marker for stratifying cardiovascular metabolic comorbidities among the middle-aged and elderly adults
Danhui Mao1,2, Sheng Zhao1, Jiao Lu3
1Shanxi Medical University, Taiyuan, China.
Insights
This study introduces a novel digital marker to classify Cardiovascular Metabolic Comorbidities (CMM) into risk groups. This tool integrates network analysis and machine learning for improved CMM subgroup identification and risk stratification.
Area of Science:
- Cardiovascular and Metabolic Diseases
- Computational Biology and Bioinformatics
- Machine Learning in Healthcare
Background:
- Cardiovascular Metabolic Comorbidities (CMM) share underlying mechanisms like inflammation and insulin resistance, leading to complex interactions.
- Current methods for describing CMM status based solely on clinical features are insufficient.
- Distinct CMM subgroups require systematic characterization for effective management.
Purpose of the Study:
- To develop a digital marker for characterizing CMM subgroups based on cross-sectional data.
- To systematically reveal distinct CMM subgroups using network analysis and machine learning.
- To assess the potential of the digital marker for early detection and stratified interventions.
Main Methods:
- Constructed a directed acyclic network for CMM using demographic, clinical laboratory, and disease data via the DirectLiNGAM algorithm.
- Analyzed network features (in-degree, out-degree, centrality measures) to rank node importance and select key clinical parameters.
- Evaluated ten machine learning algorithms for digital marker generation, with Ridge regression showing optimal performance.
- Binned digital markers to classify CMM into Low, Middle, and High risk groups.
Main Results:
- Network analysis identified key clinical parameters (e.g., GLU, HBALC, TC) and demographic factors (e.g., Male) influencing CMM.
- Ridge regression demonstrated superior performance in predicting mortality (AUC, PR-AUC, Brier Score, Log Loss).
- The developed digital marker effectively classified CMM into Low, Middle, and High risk groups with distinct average scores.
Conclusions:
- A novel digital marker integrating network analysis and machine learning effectively delineates CMM subgroups.
- This digital marker holds potential for early detection of CMM risk.
- The findings support future research on stratified interventions for high-risk CMM groups.
Abstract:
Cardiovascular Metabolic Comorbidities (CMM) share common physiological mechanisms in inflammation and immunity, oxidative stress, and insulin resistance, leading to mutual disease interactions and complex clinical manifestations. To address challenges in describing CMM status based solely on clinical features, this paper proposes a digital marker to characterize the differences from single to multiple diseases, systematically revealing distinct CMM subgroups based on cross-sectional data. This paper constructed a directed acyclic network for CMM using demographic characteristics, clinical laboratory parameters, and disease status as nodes via the DirectLiNGAM algorithm. Network features were described using in degree, out degree, degree centrality, betweenness centrality, and closeness centrality, ranking node importance. The top seven significant clinical laboratory parameters were selected based on this ranking. Subsequently, the performance of ten machine learning algorithms (Random Forest, XGBoost, MLP, KNN, Gradient Boosting, SVC, Linear Regression, Ridge, ElasticNet, Lasso) in generating digital markers by predicting death was evaluated to determine the optimal algorithm. The generated digital markers were then binned to classify CMM into Low, Middle, and High groups. Finally, linear regression validated the rationality of the network filtered clinical laboratory parameters. In the CMM network, the top three disease nodes by in degree are DM, MemD, and DL, while the top five by out degree are TC, HBALC, GLU, HCT, and HGB. Regarding network centrality, the top five nodes by degree centrality are Male, TG, DM, CYC, and DL; by betweenness centrality, Male, Stroke, TG, DL,and DM; and by closeness centrality, Male, DM, Married, Stroke, and CA. Network analysis identified top clinical laboratory parameters as GLU, HBALC, TC, UA, HCT, TG, HGB, WBC, and CYC, consistent with statistically significant parameters (P < 0.05) in linear regression validation. Among machine learning algorithms, Ridge regression performed best in AUC, PR‑AUC, Brier Score, and Log Loss. The digital marker generated by Ridge regression yielded average scores of 0.016(0.008), 0.058(0.019), 0.296(0.197) for Low, Middle, and High groups, respectively. This paper developed a digital marker by integrating network analysis and machine learning to delineate CMM's cross‑sectional subgroups, indicating its potential for early detection and enabling future research on stratified interventions for high risk groups.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
